2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow Speech Intelligibility: new trials by email Literature Review of Speech Intelligibility trials Research Report on Speech Intelligibility
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Methylphenidate in Childhood Apraxia of Speech Methylphenidate Hydrochloride, Placebo - Childhood Apraxia of Speech | Phase 2 | Completed | Murdoch Childrens Research Institute | 18 | 2022-03-14 | 2026-10-13 |
| Building Sentences With Preschoolers Who Use AAC AAC Generative Language Intervention, Standard of Care / Business as Usual - Down Syndrome, Speech and Language Disorder | Phase 2 | Completed | University of Central Florida | 70 | 2018-05-11 | 2024-01-08 |
Apraxias (1) · Attention Deficit Disorder with Hyperactivity (1) · Down Syndrome (1) · Language Disorders (1) · Speech (1) · Speech Sound Disorder (1)
Behavior (2) · Communication (2) · Mental Disorders (2) · Nervous System Diseases (2) · Neurobehavioral Manifestations (2) · Neurodevelopmental Disorders (2) · Neurologic Manifestations (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Verbal Behavior (2) · Abnormalities, Multiple (1) · Attention Deficit and Disruptive Behavior Disorders (1) · Chromosome Disorders (1) · Communication Disorders (1) · Congenital Abnormalities (1)
Commerce (1) · Methylphenidate (1) · Standard of Care (1)
Murdoch Childrens Research Institute (1) · University of Central Florida (1)
Australia (1) · United States (1)
R01DC016321 (1)